In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Bryan Durkin Biography and Net Worth

Director of CME Group

Mr. Durkin has served as a member of our board and as an advisor to our CEO since May 2020. Formerly, Mr. Durkin served as President of CME Group from 2016, overseeing the company’s Technology, Global Operations, International and Data Services businesses. Mr. Durkin previously served as our Chief Commercial Officer since 2014 and as Chief Operating Officer since 2007. As part of his responsibilities, he led the global integrations following CME’s merger with CBOT in 2007 and CME Group’s acquisition of NYMEX in 2008. Before joining CME Group, Mr. Durkin served as Executive Vice President and Chief Operating Officer of the CBOT. Prior to that role, he was in charge of CBOT’s Office of Investigations and Audits. His career with both CME Group and CBOT has spanned more than 30 years. He previously served as a member of the COMEX Governors Committee and the CFTC’s Technology Advisory Committee and Energy and Environmental Markets Advisory Committee. Mr. Durkin serves on the Board of Advisors for Misericordia and on the Board of Trustees for Lewis University.

What is Bryan T. Durkin's net worth?: The estimated net worth of Bryan T. Durkin is at least $12.74 million as of August 30th, 2024. Mr. Durkin owns 55,607 shares of CME Group stock worth more than $12,736,227 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Durkin may own. Learn More about Bryan T. Durkin's net worth.
How do I contact Bryan T. Durkin?: The corporate mailing address for Mr. Durkin and other CME Group executives is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. CME Group can also be reached via phone at (312) 930-1000 and via email at [email protected]. Learn More on Bryan T. Durkin's contact information.
Has Bryan T. Durkin been buying or selling shares of CME Group?: Bryan T. Durkin has not been actively trading shares of CME Group during the last quarter. Most recently, Bryan T. Durkin sold 7,593 shares of the business's stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a transaction totalling $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company's stock, valued at $11,932,706.13. Learn More on Bryan T. Durkin's trading history.
Who are CME Group's active insiders?: CME Group's insider roster includes Timothy Bitsberger (Director), Charles Carey (Director), Elizabeth Cook (Director), Kathleen Cronin (Insider), Sunil Cutinho (Insider), Terrence Duffy (Chairman & CEO), Bryan Durkin (Director), Lynne Fitzpatrick (Senior Managing Director & Deputy CFO), Martin Gepsman (Director), Phupinder Gill (CEO), Daniel Glickman (Director), Julie Holzrichter (COO), Kevin Kometer (Insider), Timothy McCourt (Insider), Hilda Piell (Insider), John Pietrowicz (CFO), Derek Sammann (Insider), Terry Savage (Director), Terry Savage (Director), William Shepard (Director), Howard Siegel (Director), Dennis Suskind (Director), Jack Tobin (CAO), Sean Tully (Insider), Ken Vroman (Insider), and Julie Winkler (Insider). Learn More on CME Group's active insiders.
Are insiders buying or selling shares of CME Group?: In the last year, CME Group insiders bought shares 5 times. They purchased a total of 109 shares worth more than $22,402.94. In the last year, insiders at the financial services provider sold shares 16 times. They sold a total of 88,049 shares worth more than $18,813,672.55. The most recent insider tranaction occured on November, 4th when Director Martin J Gepsman sold 400 shares worth more than $89,168.00. Insiders at CME Group own 0.3% of the company. Learn More about insider trades at CME Group.
Information on this page was last updated on 11/4/2024.

Bryan T. Durkin Insider Trading History at CME Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Sell	7,593	$214.59	$1,629,381.87	55,607
12/11/2023	Sell	5,560	$216.37	$1,203,017.20	62,452
11/5/2021	Sell	10,000	$222.07	$2,220,700.00
2/19/2021	Sell	11,000	$195.58	$2,151,380.00	74,650
8/6/2018	Sell	11,509	$162.01	$1,864,573.09	64,862
8/8/2017	Sell	9,200	$125.13	$1,151,196.00	70,938
12/28/2016	Sell	14,886	$116.39	$1,732,581.54	65,960
11/30/2016	Sell	15,000	$112.85	$1,692,750.00	68,680
10/31/2016	Sell	15,000	$100.00	$1,500,000.00	58,454
9/28/2016	Sell	14,990	$105.10	$1,575,449.00	66,936
9/6/2016	Sell	15,000	$107.75	$1,616,250.00	63,967
9/2/2014	Sell	25,625	$76.75	$1,966,718.75

Bryan T. Durkin Buying and Selling Activity at CME Group

CME Group Company Overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

Today's Range

Now: $229.04

$226.91

$229.94

50 Day Range

MA: $223.64

$213.16

$229.69

2 Week Range

Now: $229.04

$190.70

$230.74

Volume

3,050,367 shs

Average Volume

1,678,930 shs

Market Capitalization

$82.54 billion

P/E Ratio

24.08

Dividend Yield

2.03%

Beta

0.55

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad